Other studies have shown that the inhibition of miR-33-5p in mice with atherosclerosis leads to a significant increase in ABCA1 expression, promoting the reverse transport of cholesterol and the reduction of atherosclerotic injury [12,17,18,19]. Here, ABCA1 is linked to atherosclerosis.